Anticoagulant Sodium Citrate Solution USP, 250 mL VIAFLEX Plastic Container recall
Baxter International Inc. announced this recall on Aug 25, 2026. FDA has not yet published its classification (Class I, II or III) for it; that usually follows within a few weeks, and this page will then point to the classified recall.
Why it was recalled
Potential presence of particulate matter identified as fiberglass in the solution
Cause type: Particulate / foreign matter
Visible foreign particles - glass, metal, fibers or other material - found in the product. Particles can enter from equipment wear, containers or the process, and are dangerous in injectables.
What was recalled
Anticoagulant Sodium Citrate Solution USP, 250 mL VIAFLEX Plastic Container
Compare with the code on your package — the lot numbers are listed in FDA’s notice.
Product details
From the FDA NDC directory, for the product code in this announcement.
| Product | Strength | Form & route | Labeler |
|---|---|---|---|
| Anticoagulant Sodium Citrate NDC 00338-9669 |
40 mg/mL | Solution Extracorporeal |
Baxter Healthcare Corporation |
- Company
- Baxter International Inc.
- Brand
- Baxter
- Company announcement
- Aug 25, 2026
- Posted by FDA
- Aug 25, 2026
Check your lot number. Firm-announced recalls are usually the serious ones. Find the lot number on your package and compare it with the lots listed in FDA’s notice; if it matches, do not use it and speak to your pharmacist or prescriber today. Do not stop a prescribed medication without advice.
Free recall alerts
Know the day your medication is recalled
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.